Avidity Biosciences stock gains 4.79 percent as RNA trades at USD 9.18

Published on 09/22/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Avidity Biosciences stock traded at USD 9.18 on September 22, 2026, up 4.79 percent from the prior close. The 52-week range spans USD 8.67 to USD 73.05.

RNA, US05070P1075, Illustration mit AI erstellt.

Avidity Biosciences stock traded at USD 9.18 on Nasdaq on September 22, 2026, up USD 0.42, or 4.79 percent, from the prior close of USD 8.76. The quote was recorded at 1:29 a.m. IST, while the session range stood at USD 9.07 to USD 9.34.

RNA remains near yearly low

The market data show a wide 52-week range of USD 8.67 to USD 73.05 as of September 22, 2026. At USD 9.18, the stock was USD 0.51 above the yearly low and USD 63.87 below the yearly high, putting the current quote 99.30 percent below the high.

Trading volume was 23,714 shares on September 22, 2026, and the reported market capitalization was USD 1.02 billion on the same date. The daily gain therefore came against a valuation that remains far below the 52-week peak.

Corporate action changes the ticker

Robinhood reported on September 22, 2026, that Avidity Biosciences performed a ticker change to RNAM. The change is a concrete trading identifier event for investors tracking the security, although the quoted market page still labels the instrument as RNA.

Nasdaq context adds contrast

The Nasdaq Composite closed at 27,122.09 on September 21, 2026, gaining 599.55 points, or 2.26 percent, according to a market report published on September 22, 2026. RNA's USD 9.18 quote and 52-week range show a company-specific trading profile that is materially different from the broader index backdrop.

RNA closes at USD 9.18

Avidity Biosciences stock stood at USD 9.18 on Nasdaq as of September 22, 2026, with a daily change of 4.79 percent and a 52-week range of USD 8.67 to USD 73.05.